LeonaBio, Inc. Common Stock
$6.79
Market Cap
$68.21M
Shares Outstanding
9.4M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Sep 18, 2020
Round Lot
100
Locale
US
Day Open
$7.10
Day High
$7.30
Day Low
$6.70
Volume
51.3K
VWAP
$7.00
Prev Close
$7.24
Transactions
--
Acc. Volume
--
LeonaBio Inc is a clinical-stage biopharmaceutical company focused on the development of novel therapeutics for high unmet medical needs. Its key drug candidates, lasofoxifene and ATH-1105, are novel, small-molecule therapies with the potential to address treatment-resistant metastatic breast cancer and amyotrophic lateral sclerosis (ALS). LeonaBio is also exploring the use of other drug candidates that enhance the neurotrophic HGF system, including ATH-1020, to improve neuronal health and function in multiple neurological diseases. In addition, it is also focused on designing and testing new early compounds directed towards novel targets for a variety of clinical applications. The company operates as a single operating segment, developing and commercializing therapeutics.
LeonaBio, Inc. Common Stock (LONA) closed the 2026-09-16 session at $6.79, down 6.22% versus the previous close (-0.45). The stock opened at $7.10 and traded between $6.70 and $7.30 during that session. Session trading volume was 51K shares. The volume-weighted average price (VWAP) is $7.00.
LeonaBio Inc is a clinical-stage biopharmaceutical company focused on the development of novel therapeutics for high unmet medical needs. Its key drug candidates, lasofoxifene and ATH-1105, are novel, small-molecule therapies with the potential to address treatment-resistant metastatic breast cancer and amyotrophic lateral sclerosis (ALS). LeonaBio is also exploring the use of other drug candidates that enhance the neurotrophic HGF system, including ATH-1020, to improve neuronal health and function in multiple neurological diseases. In addition, it is also focused on designing and testing new early compounds directed towards novel targets for a variety of clinical applications. The company operates as a single operating segment, developing and commercializing therapeutics.
LeonaBio, Inc. Common Stock has a market capitalization of $68.2 million. The company operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) industry classification. LONA is listed on the XNAS exchange. The company employs approximately 19 people. LeonaBio, Inc. Common Stock is headquartered in BOTHELL, WA. The recorded listing date is 2020-09-18.
On this page you can find market LONA stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.